During the past decade, Hospital de Cruces; Servicio de Neurologia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Cruces; Servicio de Neurologia" #1 collaborator was "PPD" with 1 trials as a collaborator and "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Cruces; Servicio de Neurologia" are "Alzheimer's Disease" (5 trials), "Huntingtons Disease" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials), "Parkinsons Disease" (1 trials) and "Relapsing-Remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Hospital de Cruces; Servicio de Neurologia" in a lesser frequency.

Most popular intervention types in "Hospital de Cruces; Servicio de Neurologia" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Gantenerumab" (2 trials), "Ocrelizumab" (2 trials), "Crenezumab" (1 trials) and "Fingolimod" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Cruces; Servicio de Neurologia" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hospital de Cruces; Servicio de Neurologia". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital de Cruces; Servicio de Neurologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Cruces; Servicio de Neurologia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".